Table 3.
Summary of likely pathogenic variants among sudden cardiac death victims with presumed acquired cardiac disease.
| Mutated gene | Subject no | Decade of life, gender | Presumed etiology of LVH | Heart weight, g | Myocardial fibrosis at autopsy | Nucleotide change | Effect on protein | Predicted effect | NGS coverage | gnomAD > 10,000 Finnish controls MAF | SISu > 10,000 Finnish controls MAF | ACMG score16 | ClinVar adjudication |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCC9 | 1 | 60M | Hypertension | 476 | Moderate patchy | 565C>T | Arg189Ter | Truncating | 175 | 0.0011 | 0.0008 | PVS1 + PM4 + PP3 | N/A |
| ACTN2 | 2 | 50M | Hypertension | 427 | Scattered mild | 26A>G | Gln9Arg | Missense | 261 | 0.0002 | 0.0001 | PS3 + PP2 + PP4 (DCM, HCM) | Conflicting |
| ANKRD1 | 3 | 50M | Hypertension | 446 | Scattered mild | 197G>A | Arg66Gln | Missense | 369 | 0.0015 | 0.0012 | PS4 + PP3 + PP4 (DCM) | Conflicting |
| ANKRD1 | 4 | 70M | Obesity | 440 | Scattered mild | 197G>A | Arg66Gln | Missense | 353 | 0.0015 | 0.0012 | PS4 + PP3 + PP4 (DCM) | Conflicting |
| ANKRD1 | 5 | 30M | Obesity | 525 | Moderate patchy | 197G>A | Arg66Gln | Missense | 160 | 0.0015 | 0.0012 | PS4 + PP3 + PP4 (DCM) | Conflicting |
| CAV3 | 6 | 50M | Hypertension | 463 | Scattered mild | 233C>T | Thr78Met | Missense | 181 | 0.0032 | 0.0025 | PS1 + PP3 + PP4 (LQTS) | Conflicting |
| CAV3 | 7 | 50M | Obesity | 411 | Scattered mild | 233C>T | Thr78Met | Missense | 46a | 0.0032 | 0.0025 | PS1 + PP3 + PP4 (LQTS) | Conflicting |
| DES | 8 | 60M | Hypertension | 476 | Scattered mild | 934G>A | Asp312Asn | Missense | 248 | Not detected | Not detected | PS3 + PM1 + PM2 + PP2 + PP3 + PP4 (DCM) + PP5 | VUS |
| DSG2 | 9 | 80F | Hypertension | 529 | Moderate patchy | 1174G>A | Val392Ile | Missense | 58 | 0.0009 | 0.0009 | PS4 + PP2 + PP3 + PP4 (ACM) | Conflicting |
| DSG2 | 10 | 70F | Hypertension | 620 | Some fibrosis | 1174G>A | Val392Ile | Missense | 119 | 0.0009 | 0.0009 | PS4 + PP2 + PP3 + PP4 (ACM) | Conflicting |
| LMNA | 11 | 50M | Hypertension | 454 | Moderate patchy | 504G>C | Gln168His | Missense | 77 | Not detected | Not detected | PM1 + PM2 + PP2 + PP3 | VUS |
| MYH6 | 8 | 60M | Hypertension | 476 | Scattered mild | 346-2A>G | Affects canonical splicing | 112 | Not detected | Not detected | PVS1 + PM2 | VUS | |
| MYH6 | 12 | 50M | Obesity | 673 | Some fibrosis | 3195G>C | Gln1065His | Missense | 319 | 0.0017 | 0.0017 | PS1 + PM1 + PP3 + PP4 (HCM) | Conflicting |
| MYH7 | 13 | 50M | Obesity | 472 | Moderate patchy | 2945 T>C | Met982Thr | Missense | 95 | 0.0005 | 0.0005 | PS1 + PM1 + PP2 + PP3 + PP4 (HCM) | Benign |
| PKP2 | 14 | 50M | Obesity | 651 | Moderate patchy | 1114G>C | Ala372Pro | Missense | 23a | 0.0023 | 0.0023 | PM6 + PP2 + PP3 + PP4 (ACM) | Conflicting |
| TCAP | 15 | 40M | Obesity | 530 | Some fibrosis | 458G>A | Arg153His | Missense | 131 | 0.0022 | 0.0019 | PS1 + PP1 + PP2 + PP4 (HCM) | Conflicting |
ACMG American college of molecular genetics, ACM arrhythmogenic cardiomyopathy, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, LQTS long QT syndrome, LVH left ventricle hypertrophy, MAF minor allele frequency, NGS next generation sequencing, VUS variant of uncertain significance.
aVerified by Sanger sequencing.